Hypertrophic cardiomyopathy in childhood - Wikidata - wikimedia - TriplyDB

Hypertrophic cardiomyopathy in childhood

Hypertrophic cardiomyopathy in childhood

http://www.wikidata.org/entity/Q24599577

about

Spectrum of heart diseases in children: an echocardiographic study of 1,666 subjects in a pediatric hospital, Yaounde, Cameroon.Predictors of Long-Term Outcome in Children with Hypertrophic Cardiomyopathy.Cardiomyopathy and heart failure in children: anesthetic implications.Cardiological manifestations of mitochondrial respiratory chain disorders.Heart transplantation in pediatric cardiomyopathies.Discrimination of the "Athlete's Heart" from real disease by electrocardiogram and echocardiogram.Survival and prognostic factors in hypertrophic cardiomyopathy: a meta-analysis.PRKAG2 mutations presenting in infancy.Cardiovascular magnetic resonance imaging in hypertrophic cardiomyopathy: the importance of clinical context.T1 mapping in children and young adults with hypertrophic cardiomyopathy.Co-occurrence of hypertrophic cardiomyopathy and myeloproliferative disorder in a neonate with Noonan syndrome carrying Thr73Ile mutation in PTPN11.

P2860

Q36516393-B32C92B0-2ED6-494F-A3E1-04980002B30B Q36762345-1DC1DFBF-A77A-4A0A-9E0B-4D59DC57FBA7 Q37863732-17DC1FBB-9ED4-483E-98BB-6C22219D2023 Q37917716-163BBFB5-D8E8-4F7C-A4B6-CD6A3DA577F1 Q38161524-2E76538E-B8B4-4392-9B22-061289CE7739 Q39085573-7CC68B12-6DBF-49C7-8E3C-111FA2CCBBEF Q41696597-89EB0760-B3DA-46D8-A30F-CFBB93165CD4 Q47961939-F02377FC-7AD7-4166-87DA-F60830C80581 Q50138783-12D78F96-C215-44E7-A574-DFC53A1E104F Q51155770-432406E8-EC42-4E0E-853A-A68BB5CB6BBB Q53374749-9AC743DF-0CAA-4542-B96D-7DC6AE31496E

P2860

Hypertrophic cardiomyopathy in childhood

http://www.wikidata.org/entity/Q24599577

description

2010 nî lūn-bûn

@nan

2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Hypertrophic cardiomyopathy in childhood

@ast

Hypertrophic cardiomyopathy in childhood

@en

Hypertrophic cardiomyopathy in childhood

@nl

type

label

Hypertrophic cardiomyopathy in childhood

@ast

Hypertrophic cardiomyopathy in childhood

@en

Hypertrophic cardiomyopathy in childhood

@nl

prefLabel

Hypertrophic cardiomyopathy in childhood

@ast

Hypertrophic cardiomyopathy in childhood

@en

Hypertrophic cardiomyopathy in childhood

@nl

P1433

Q24599577-87ADA7B6-DBBA-459D-9382-3AE4D7800882

P1476

Q24599577-EFE91813-39EF-4DDC-9821-38A2FF2E5A25

P2093

Q24599577-ACC47C57-28B9-4919-80C2-F7E82C2DCE16

P2860

Q24599577-011D6C39-CF11-438C-A8DE-C47513A30D1B

Q24599577-0672A767-4E66-4302-9852-071C00B42AD1

Q24599577-091514D8-385E-4045-B107-6D9B8537DDF6

Q24599577-0B09FA64-E393-495E-A2C5-C5757587E2CE

Q24599577-0D18DC87-E759-4BCB-B71A-5A5355FF94F8

Q24599577-11D6BB6E-87F5-4077-8CFB-ED9F0823EB36

Q24599577-1FD6D543-64CA-4A8B-B776-C35CB8B5A7C5

Q24599577-211637F0-91D3-4688-AC6A-F9EB04FE455A

Q24599577-23F3537C-2D99-471E-9389-8F88E2D36CE2

Q24599577-25274DC7-25E7-4A7D-8A7A-82F30A5114EE

P304

Q24599577-ED372E9D-9A0C-485E-91BF-3E13631D1093

P31

Q24599577-EE8DCC78-D027-4815-89D4-C6D664B9810B

P356

Q24599577-E9C80B2D-2757-4059-997C-7646D1E8EEEC

P407

Q24599577-3702EEAC-1F00-4A3F-81B5-D5E5084F98D0

P433

Q24599577-3EC21F8F-AFDA-4A38-8742-7A2ABA9D3711

P478

Q24599577-ED547EEA-1FDA-49F8-B7EB-F411E47B7609

P577

Q24599577-8B87984A-52B2-456F-9DFB-421D27CD20F7

P5875

Q24599577-A9CB35C3-C8F7-4291-8D6B-116F0DD792FC

P698

Q24599577-FC712EA6-0B47-4CA1-BCE7-5D77A9EC2B52

P932

Q24599577-0D733472-F06F-4587-9A05-5F56EF74EFD2

P356

J.HFC.2010.05.004

P1433

Heart failure clinics

P1476

Hypertrophic cardiomyopathy in childhood

@en

P2093

Steven D Colan

http://www.w3.org/2001/XMLSchema#string

P2860

Constitutively active AMP kinase mutations cause glycogen storage disease mimicking hypertrophic cardiomyopathy

Severe disease expression of cardiac troponin C and T mutations in patients with idiopathic dilated cardiomyopathy

Sudden death due to troponin T mutations

Aldosterone, through novel signaling proteins, is a fundamental molecular bridge between the genetic defect and the cardiac phenotype of hypertrophic cardiomyopathy

Hypertrophic cardiomyopathy in a large community-based population: clinical outcome and identification of risk factors for sudden cardiac death and clinical deterioration.

Impact of dual-chamber permanent pacing in patients with obstructive hypertrophic cardiomyopathy with symptoms refractory to verapamil and beta-adrenergic blocker therapy.

Implications of implantable cardioverter defibrillator therapy in congenital heart disease and pediatrics.

Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy.

Prevalence of exercise-induced left ventricular outflow tract obstruction in symptomatic patients with non-obstructive hypertrophic cardiomyopathy.

Syncope and risk of sudden death in hypertrophic cardiomyopathy.

P304

433-44, vii-iii

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.HFC.2010.05.004

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P577

2010-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

46426153

http://www.w3.org/2001/XMLSchema#string

P698

20869644

http://www.w3.org/2001/XMLSchema#string

P932

2946944

http://www.w3.org/2001/XMLSchema#string